Nrf2 Activator PB125® as a Potential Therapeutic Agent Against COVID-19
Nrf2 is a transcription factor that regulates cellular redox balance and the expression of a wide array of genes involved in immunity and inflammation, including antiviral actions. Nrf2 activity declines with age, making the elderly more susceptible to oxidative stress-mediated diseases, which include type 2 diabetes, chronic inflammation, and viral infections. Published evidence suggests that Nrf2 activity may regulate important mechanisms affecting viral susceptibility and replication. We examined gene expression levels by GeneChip microarray and by RNA-seq assays. We found that the potent Nrf2 activating composition PB125® downregulates ACE2 and TMPRSS2 mRNA expression in human liver-derived HepG2 cells. ACE2 is a surface receptor and TMPRSS2 activates the spike protein for SARS-Cov-2 entry into host cells. Furthermore, in endotoxin-stimulated primary human pulmonary artery endothelial cells we report the marked downregulation by PB125 of 36 genes encoding cytokines. These include IL1-beta, IL6, TNF-α the cell adhesion molecules ICAM1, VCAM1, and E-selectin, and a group of IFN-γ-induced genes. Many of these cytokines have been specifically identified in the "cytokine storm" observed in fatal cases of COVID-19, suggesting that Nrf2 activation may significantly decrease the intensity of the storm.
| Errataetall: |
UpdateIn: Antioxidants (Basel). 2020 Jun 12;9(6):. - PMID 32545518 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - year:2020 |
|---|---|
| Enthalten in: |
bioRxiv : the preprint server for biology - (2020) vom: 10. Juni |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
McCord, Joe M [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
ACE2 |
|---|
| Anmerkungen: |
Date Revised 14.01.2022 published: Electronic UpdateIn: Antioxidants (Basel). 2020 Jun 12;9(6):. - PMID 32545518 Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.1101/2020.05.16.099788 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM310908418 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM310908418 | ||
| 003 | DE-627 | ||
| 005 | 20231225141117.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1101/2020.05.16.099788 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1036.xml |
| 035 | |a (DE-627)NLM310908418 | ||
| 035 | |a (NLM)32511372 | ||
| 035 | |a (PII)2020.05.16.099788 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a McCord, Joe M |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Nrf2 Activator PB125® as a Potential Therapeutic Agent Against COVID-19 |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 14.01.2022 | ||
| 500 | |a published: Electronic | ||
| 500 | |a UpdateIn: Antioxidants (Basel). 2020 Jun 12;9(6):. - PMID 32545518 | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a Nrf2 is a transcription factor that regulates cellular redox balance and the expression of a wide array of genes involved in immunity and inflammation, including antiviral actions. Nrf2 activity declines with age, making the elderly more susceptible to oxidative stress-mediated diseases, which include type 2 diabetes, chronic inflammation, and viral infections. Published evidence suggests that Nrf2 activity may regulate important mechanisms affecting viral susceptibility and replication. We examined gene expression levels by GeneChip microarray and by RNA-seq assays. We found that the potent Nrf2 activating composition PB125® downregulates ACE2 and TMPRSS2 mRNA expression in human liver-derived HepG2 cells. ACE2 is a surface receptor and TMPRSS2 activates the spike protein for SARS-Cov-2 entry into host cells. Furthermore, in endotoxin-stimulated primary human pulmonary artery endothelial cells we report the marked downregulation by PB125 of 36 genes encoding cytokines. These include IL1-beta, IL6, TNF-α the cell adhesion molecules ICAM1, VCAM1, and E-selectin, and a group of IFN-γ-induced genes. Many of these cytokines have been specifically identified in the "cytokine storm" observed in fatal cases of COVID-19, suggesting that Nrf2 activation may significantly decrease the intensity of the storm | ||
| 650 | 4 | |a Preprint | |
| 650 | 4 | |a ACE2 | |
| 650 | 4 | |a ALI | |
| 650 | 4 | |a COVID-19 | |
| 650 | 4 | |a CXCL10 | |
| 650 | 4 | |a HDAC5 | |
| 650 | 4 | |a LIF | |
| 650 | 4 | |a NFE2L2 | |
| 650 | 4 | |a Nrf2 | |
| 650 | 4 | |a SARS-CoV-2 | |
| 650 | 4 | |a TMPRSS2 | |
| 650 | 4 | |a coronavirus | |
| 650 | 4 | |a cytokine storm | |
| 700 | 1 | |a Hybertson, Brooks M |e verfasserin |4 aut | |
| 700 | 1 | |a Cota-Gomez, Adela |e verfasserin |4 aut | |
| 700 | 1 | |a Gao, Bifeng |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t bioRxiv : the preprint server for biology |d 2020 |g (2020) vom: 10. Juni |w (DE-627)NLM31090014X |7 nnns |
| 773 | 1 | 8 | |g year:2020 |g day:10 |g month:06 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1101/2020.05.16.099788 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |j 2020 |b 10 |c 06 | ||